After reaching an important support level, Y-mAbs Therapeutics, Inc. (YMAB) could be a good stock pi

NEW YORK CITY and NEW ORLEANS, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisian

Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire'

Y-mAbs Therapeutics, Inc. (YMAB) came out with a quarterly loss of $0.07 per share versus the Zacks

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Y-mAbs (NASDAQ: YMAB) for possible breac

Y-mAbs Therapeutics (YMAB), a biopharmaceutical company focused on developing and commercializing an

PRINCETON, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mA

NEW YORK , Aug. 7, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Ass

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mA

YmAbs Therapeutics (YMAB) saw its shares surge in the last session with trading volume being higher

Morgan Stanley upgraded Y-mAbs Therapeutics to Equal Weight from Underweight with a price target of

Canaccord downgraded Y-mAbs Therapeutics to Hold from Buy with a price target of $8.60, down from $2

Oppenheimer analyst Jeff Jones downgraded Y-mAbs Therapeutics without a price target to Perform from

Brookline analyst Kemp Dolliver downgraded Y-mAbs Therapeutics to Hold from Buy with an $8.60 price

Truist downgraded Y-mAbs Therapeutics to Hold from Buy with a price target of $8.60, down from $14,

MILWAUKEE , Aug. 5, 2025 /PRNewswire/ -- The Ademi Firm is investigating Y-mAbs (NASDAQ: YMAB) for p

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Acquisition to Include Naxitamab-gqgk DANYELZA ® ( Naxitamab-gqgk) , Further Broadening SERB's Rare

YmAbs Therapeutics (YMAB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism ab

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-q

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 pe

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quart

  On Friday, 469 companies hit new 52-week lows.

  On Thursday, 175 stocks hit new 52-week lows.

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique

Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus T

  On Tuesday, 85 stocks hit new 52-week lows.

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on M

  During Monday's session, 96 stocks hit new 52-week lows.